Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Xelpros vs Reference Latanoprost in Glaucoma or Ocular Hypertension
NCT00947661Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Jul 2010
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of latanoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Sun Pharma. Started Jul 2010; status: completed.
02
Drugs
latanoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00947661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947661.